At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Vitamin D3 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Suplementation of 5,000 UI Vitamin D3 on the Glycemic Profile in Patients With Gestational Diabetes Mellitus of the Hospital Civil de Guadalajara Dr. Juan I. Menchaca
In Brief
A clinical study evaluating Vitamin D3 and Capsules with placebo (talcum food grade) for Vitamin D3 and Gestational Diabetes Mellitus in Pregnancy. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Randomized double-blind placebo-controlled clinical trial. Consists of the administration of 5,000 IU of vitamin D3 vs Placebo in patients with gestational diabetes mellitus during eight weeks. The objective is to analyze the effects of the intervention on the biochemical parameters that are part of the glycemic profile (insuline, HBA1c, glucose)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartFeb 2020
Primary CompletionFeb 2020
Study CompletionMar 2020
TodayJul 2026
First PostedAug 24, 2018
Enrollment StartFeb 28, 2020
Primary CompletionFeb 28, 2020
Study CompletionMar 10, 2020
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 7.9 years ago
Interventions
Vitamin D3dietary
Capsules with 5,000 IU of vitamin D3 once a day (one capsule)
Capsules with placebo (talcum food grade)other
Capsules with placebo (talcum food grade)